4Kumar, P, Herndon Ⅱ J, Kanger M, et al. Patterns of disease failure after trimodality therapy of non-small cell lung carcinoma pathologic stage Ⅲ a( N2 ) [ J ]. Cancer, 1996,77 (11): 2393-2399.
5Elias AD, Skarin AT, Leong T, et al. Neoadjuvant therapy for surgically staged Ⅲ a N2 non-small cell lung cancer (NSCLC)[ J]. Lung cancer,1997,17:147-161.
6Wright SE, Sicola VR, Martinez H, et al. Adjuvant chemotherapy and radiation therapy for elimination of residual microscopic non-small cell lung cancer[ J ]. Int J Oncol, 1999,14: 347-351.
7Parkin DM.Estimates of the worldwide incidence of eighteen in 1985[J].Int J Cancer,1993,54(4):594-606.
8Furuse K,Kawahara M,Nishiwaki Y,et al.Phase Ⅲ study of concurrent versus sequential thoraccic radiotherapy in combination with mitomycin,vinblastine and cisplatin in unresectable stage Ⅲ non-small cell Lung caner[J].J Clin Oncol,1999,17(9):2692-2699.
9Minna JD,Pass H,Galtstein E,et al.Cancer of the Lung[A].Devita VT Jr,Jaffe ES,Mauch P.Cancer,Prineiples and Practice of Oncology[M].3rded.Philadelphia:Lippincott,1989.591-705.
